News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Conference News HFSA 2020 EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes L.A. McKeown October 09, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Daily News HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds Michael O'Riordan August 13, 2020
News Daily News Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades Yael L. Maxwell May 28, 2020
News Features COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention Michael O'Riordan April 24, 2020
News Conference News ISC 2020 SKIP Questions Need for IV Thrombolysis Before Stroke Thrombectomy Todd Neale February 25, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020